The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025
Read more at globenewswire.comNorthwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
RENOVORX INC
NASDAQ:RNXT (2/7/2025, 8:00:01 PM)
After market: 1.16 0 (0%)1.16
-0.3 (-20.55%)
RNXT Latest News and Analysis
17 hours ago - ChartmillWhat's going on in today's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
a day ago - ChartmillThese stocks are moving in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
